Lataa...
Pharmacokinetic and Safety Profiles of a Fixed‐Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3‐Period Replicate Crossover Study
The objective of study was to compare the pharmacokinetic and safety profiles of a fixed‐dose combination (FDC) formulation of 5/160/20 mg amlodipine/valsartan/atorvastatin with those of separate formulations of a 5/160‐mg amlodipine/valsartan tablet and a 20‐mg atorvastatin tablet. This was a rando...
Tallennettuna:
| Julkaisussa: | Clin Pharmacol Drug Dev |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7187173/ https://ncbi.nlm.nih.gov/pubmed/31373174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.727 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|